{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:44:49Z","timestamp":1789767889801,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The lectin pathway of complement aids in removing apoptotic cells and maintenance of tissue homeostasis. However, its role in SLE pathogenesis remains unknown. This study aimed to assess the association of ficolins, mannose-binding lectin (MBL), and other pathogen recognition molecules (PRMs) of the lectin pathway and their corresponding autoantibodies with various clinical manifestations and disease activity in SLE patients from Western India. In this cross-sectional study, 282 clinically diagnosed SLE patients were included. Serum levels of ficolins, antigenic MBL, MBL-associated serine proteases (MASPs), MBL-associated protein 44 (MAp44), Collectin liver-1 (CL-L1), and their corresponding autoantibodies were quantified using ELISA. Group differences were analyzed using Mann-Whitney U tests, while associations\/relationships were evaluated using chi-square tests and Spearman\u2019s correlations. Serum levels of ficolin-2 (\n                    <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>\n                    ), MASP-3 (\n                    <jats:italic>p\u2009=\u20090.030<\/jats:italic>\n                    ), and MAp44 (\n                    <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>\n                    ) were significantly elevated, while antigenic MBL (\n                    <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>\n                    ) and MASP-1 (\n                    <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>\n                    ) were significantly reduced in SLE patients compared to healthy controls (HCs). Renal involvement was associated with elevated ficolin-1 (\n                    <jats:italic>p\u2009=\u20090.009<\/jats:italic>\n                    ), while hematological manifestations were linked to reduced MASP-1 (\n                    <jats:italic>p\u2009=\u20090.018<\/jats:italic>\n                    ), MASP-3 (\n                    <jats:italic>p\u2009=\u20090.002<\/jats:italic>\n                    ), and MAp44 (\n                    <jats:italic>p\u2009=\u20090.002<\/jats:italic>\n                    ) levels. Mucocutaneous manifestations were associated with elevated MAp44 (\n                    <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>\n                    ) and anti-ficolin-1 (\n                    <jats:italic>p\u2009=\u20090.038<\/jats:italic>\n                    ) autoantibodies. Anti-ficolin-1 (\n                    <jats:italic>p\u2009=\u20090.001<\/jats:italic>\n                    ), anti-ficolin-2 (\n                    <jats:italic>p\u2009=\u20090.001<\/jats:italic>\n                    ), and anti-ficolin-3 (\n                    <jats:italic>p\u2009&lt;\u20090.001<\/jats:italic>\n                    ) autoantibodies were significantly elevated in SLE patients compared to HCs. Anti-ficolin-2 autoantibodies were negatively correlated with ficolin-2 (\n                    <jats:italic>r<\/jats:italic>\n                    =-0.153,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.015). Anti-MBL antibodies were correlated with SLEDAI (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.169,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.007) and anti-dsDNA antibodies (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.178,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005). These findings indicate altered levels of lectin pathway-associated PRMs and their corresponding autoantibodies in SLE. Their association with clinical manifestations, disease activity, and complement-related parameters, suggest their potential as novel biomarkers in SLE.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-10891-5","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:03:35Z","timestamp":1761829415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lectin pathway components and autoantibodies as novel immunological biomarkers in systemic lupus erythematosus (SLE) patients from Western India"],"prefix":"10.1038","volume":"15","author":[{"given":"Kirti","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridi","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrutha","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshada","family":"Konkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Nadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Rajadhyaksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubka","family":"Roumenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf","family":"Parande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthami","family":"Bitla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Padwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"10891_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan, L., Lu, M. P., Wang, J. H., Xu, M. & Yang, S. R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J. Pediatr. 16, 19\u201330 (2020).","journal-title":"World J. Pediatr."},{"issue":"2","key":"10891_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/biom13020367","volume":"13","author":"M Ayano","year":"2023","unstructured":"Ayano, M. & Horiuchi, T. Complement as a biomarker for systemic lupus erythematosus. Biomolecules 13 (2), 367 (2023).","journal-title":"Biomolecules"},{"issue":"3","key":"10891_CR3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/ijms25031566","volume":"25","author":"J Dob\u00f3","year":"2024","unstructured":"Dob\u00f3, J. et al. The lectin pathway of the complement system\u2014activation, regulation, disease connections and interplay with other (proteolytic) systems. Int. J. Mol. Sci. 25 (3), 1566 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10891_CR4","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.21608\/ejhm.2021.205090","volume":"85","author":"ST Kamal","year":"2021","unstructured":"Kamal, S. T., Farres, M. N., Ibrahim, R. A., Ibrahim, I. S. & Ahmed, F. A. Anti-ficolin-2 antibody: could it be a predictor of proliferative lupus nephritis in lupus patients? Egypt. J. Hosp. Med. 85 (2), 3865\u20133871 (2021).","journal-title":"Egypt. J. Hosp. Med."},{"issue":"8","key":"10891_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/acr.23449","volume":"70","author":"S Colliard","year":"2018","unstructured":"Colliard, S. et al. Autoantibodies targeting ficolin\u20102 in systemic lupus erythematosus patients with active nephritis. Arthritis Care Res. 70 (8), 1263\u20131268 (2018).","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10891_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molimm.2014.07.003","volume":"63","author":"E Hein","year":"2015","unstructured":"Hein, E. et al. Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus. Mol. Immunol. 63 (2), 209\u2013214 (2015).","journal-title":"Mol. Immunol."},{"issue":"2","key":"10891_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cei.12678","volume":"182","author":"A Troldborg","year":"2015","unstructured":"Troldborg, A. et al. Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus. Clin. Experimental Immunol. 182 (2), 132\u2013138 (2015).","journal-title":"Clin. Experimental Immunol."},{"key":"10891_CR8","doi-asserted-by":"publisher","first-page":"103166","DOI":"10.1016\/j.jaut.2023.103166","volume":"143","author":"L Lindel\u00f6f","year":"2024","unstructured":"Lindel\u00f6f, L. et al. A survey of ficolin-3 activity in systemic lupus erythematosus reveals a link to hematological disease manifestations and autoantibody profile. J. Autoimmun. 143, 103166 (2024).","journal-title":"J. Autoimmun."},{"issue":"18","key":"10891_CR9","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1111\/jcmm.15656","volume":"24","author":"WD Xu","year":"2020","unstructured":"Xu, W. D., Liu, X. Y., Su, L. C. & Huang, A. F. Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus. J. Cell. Mol. Med. 24 (18), 10432\u201310443 (2020).","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10891_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/0961203319856089","volume":"28","author":"MA Elkoumi","year":"2019","unstructured":"Elkoumi, M. A. et al. Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study. Lupus 28 (8), 995\u20131002 (2019).","journal-title":"Lupus"},{"issue":"9","key":"10891_CR11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer, M. et al. 2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 71 (9), 1400\u20131412 (2019).","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10891_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier, C. et al. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheumatism: Official J. Am. Coll. Rheumatol. 35 (6), 630\u2013640 (1992).","journal-title":"Arthritis Rheumatism: Official J. Am. Coll. Rheumatol."},{"issue":"3","key":"10891_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2249.2004.02477.x","volume":"136","author":"R Takahashi","year":"2004","unstructured":"Takahashi, R. et al. Anti-mannose binding lectin antibodies in Sera of Japanese patients with systemic lupus erythematosus. Clin. Exp.  Immunol. 136 (3), 585\u2013590 (2004).","journal-title":"Clin. Experimental Immunol."},{"key":"10891_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-021-00984-1","volume":"23","author":"A Weinstein","year":"2021","unstructured":"Weinstein, A., Alexander, R. V. & Zack, D. J. A review of complement activation in SLE. Curr. Rheumatol. Rep. 23, 1\u20138 (2021).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10891_CR15","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3899\/jrheum.171033","volume":"45","author":"A Troldborg","year":"2018","unstructured":"Troldborg, A. et al. The lectin pathway of complement activation in patients with systemic lupus erythematosus. J. Rhuematol. 45 (8), 1136\u20131144 (2018).","journal-title":"J. Rhuematol."},{"key":"10891_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10067-016-3508-2","volume":"36","author":"N Tanha","year":"2017","unstructured":"Tanha, N., Pilely, K., Faurschou, M., Garred, P. & Jacobsen, S. Plasma Ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus. Clin. Rheumatol. 36, 335\u2013341 (2017).","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10891_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3109\/s10165-012-0616-y","volume":"22","author":"H Watanabe","year":"2012","unstructured":"Watanabe, H. et al. Serum L-ficolin levels in patients with systemic lupus erythematosus. Mod. Rheumatol. 22 (6), 899\u2013902 (2012).","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10891_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3899\/jrheum.080361","volume":"36","author":"T Andersen","year":"2009","unstructured":"Andersen, T., Munthe-Fog, L., Garred, P. & Jacobsen, S. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J. Rhuematol. 36 (4), 757\u2013759 (2009).","journal-title":"J. Rhuematol."},{"key":"10891_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4057","volume":"14","author":"AK Panda","year":"2012","unstructured":"Panda, A. K. et al. Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity. Arthritis Res. Ther. 14, 1\u20138 (2012).","journal-title":"Arthritis Res. Therapy"},{"issue":"6","key":"10891_CR20","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.4049\/jimmunol.174.6.3220","volume":"174","author":"LM Stuart","year":"2005","unstructured":"Stuart, L. M., Takahashi, K., Shi, L., Savill, J. & Ezekowitz, R. A. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 174 (6), 3220\u20133226 (2005).","journal-title":"J. Immunol."},{"issue":"3","key":"10891_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/0961203317722846","volume":"27","author":"JZ Cieslinski","year":"2018","unstructured":"Cieslinski, J. Z., Skare, T. L., Nisihara, R., De Messias-Reason, I. J. & Utiyama, S. R. Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure. Lupus 27 (3), 372\u2013379 (2018).","journal-title":"Lupus"},{"issue":"2","key":"10891_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/1721727X16646385","volume":"14","author":"I Losada Lopez","year":"2016","unstructured":"Losada Lopez, I. et al. Mannose binding lectin polymorphisms in systemic lupus erythematosus in Spain. Eur. J. Inflamm. 14 (2), 78\u201385 (2016).","journal-title":"Eur. J. Inflamm."},{"issue":"2","key":"10891_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/ard.2003.020172","volume":"64","author":"R Takahashi","year":"2005","unstructured":"Takahashi, R. et al. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann. Rheum. Dis. 64 (2), 311\u2013314 (2005).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10891_CR24","first-page":"983","volume":"29","author":"N Glesse","year":"2011","unstructured":"Glesse, N. et al. Association of the mannose-binding lectin 2 gene polymorphic variants with susceptibility and clinical progression in systemic lupus erythematosus. Clin. Expe. Rheumatology-Incl Suppl.. 29 (6), 983 (2011).","journal-title":"Clin. Experimental Rheumatology-Incl Supplements"},{"issue":"2","key":"10891_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.gene.6364283","volume":"7","author":"P Garred","year":"2006","unstructured":"Garred, P., Larsen, F., Seyfarth, J., Fujita, R. & Madsen, H. O. Mannose-binding lectin and its genetic variants. Genes Immun. 7 (2), 85\u201394 (2006).","journal-title":"Genes Immun."},{"issue":"2\u20134","key":"10891_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0161-5890(03)00104-4","volume":"40","author":"P Garred","year":"2003","unstructured":"Garred, P., Larsen, F., Madsen, H. O. & Koch, C. Mannose-binding lectin deficiency\u2014revisited. Mol. Immunol. 40 (2\u20134), 73\u201384 (2003).","journal-title":"Mol. Immunol."},{"issue":"6","key":"10891_CR27","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.4049\/jimmunol.155.6.3013","volume":"155","author":"HO Madsen","year":"1995","unstructured":"Madsen, H. O. et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. (Baltimore Md. : 1950). 155 (6), 3013\u20133020 (1995).","journal-title":"J. Immunol. (Baltimore Md. : 1950)"},{"key":"10891_CR28","doi-asserted-by":"crossref","unstructured":"Asanuma, Y. et al. Critical role of lectin pathway mediated by MBL-associated Serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus. Heliyon ;9(8). (2023).","DOI":"10.1016\/j.heliyon.2023.e19072"},{"issue":"6","key":"10891_CR29","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3899\/jrheum.141163","volume":"42","author":"A Troldborg","year":"2015","unstructured":"Troldborg, A. et al. Levels in plasma of the Serine proteases and associated proteins of the lectin pathway are altered in patients with systemic lupus erythematosus. J. Rhuematol. 42 (6), 948\u2013951 (2015).","journal-title":"J. Rhuematol."},{"issue":"9","key":"10891_CR30","doi-asserted-by":"publisher","first-page":"e0160879","DOI":"10.1371\/journal.pone.0160879","volume":"11","author":"M Plawecki","year":"2016","unstructured":"Plawecki, M. et al. Association between the presence of autoantibodies targeting ficolin-3 and active nephritis in patients with systemic lupus erythematosus. PLoS One. 11 (9), e0160879 (2016).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10891-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:03:36Z","timestamp":1761829416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10891"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10891-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37940"}}